US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Clindamycin Hydrochloride Capsules

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-144-01 D-0344-2025
Class II · Moderate risk Ongoing

Lacosamide Tablets 150mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-680-60 D-0343-2025
Class II · Moderate risk Ongoing

Pravastatin Sodium Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-196-05 D-0341-2025
Class II · Moderate risk Ongoing

Rosuvastatin Tablets 40mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-264-30 D-0339-2025
Class II · Moderate risk Ongoing

Prochlorperazine Maleate Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-890-01 D-0338-2025
Class II · Moderate risk Ongoing

Lacosamide Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-678-60 D-0337-2025
Class II · Moderate risk Ongoing

Carvedilol Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-164-05 D-0336-2025
Class II · Moderate risk Ongoing

Teriflunomide Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-424-30 D-0334-2025
Class II · Moderate risk Ongoing

Solifenacin Succinate Tablets 5mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-386-30 D-0333-2025
Class II · Moderate risk Ongoing

Saxagliptin Tablets 5mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-727-30 D-0332-2025
Class II · Moderate risk Ongoing

Lacosamide Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-679-60 D-0330-2025
Class II · Moderate risk Ongoing

Fluphenazine Hydrochloride Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-338-01 D-0326-2025
Class II · Moderate risk Ongoing

Pravastatin Sodium Tablets 80mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-198-90 D-0325-2025
Class II · Moderate risk Ongoing

Rufinamide Tablets 200mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-713-08 D-0323-2025
Class II · Moderate risk Ongoing

Lacosamide Tablets 200mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-681-60 D-0321-2025
Class II · Moderate risk Ongoing

Gabapentin Tablets 600mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-126-05 D-0320-2025